secwatch.observer — SEC 8-K summary
======================================

Issuer:     Varex Imaging Corp (VREX)
CIK:        0001681622
Form:       8-K
Filed at:   2025-11-18T23:59:59+00:00
Accession:  0001681622-25-000106
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Varex Q4 revenue $229M (+11% YoY); Non-GAAP EPS $0.37; guides Q1 $200-215M
--------------------------------------------------------------------------

- Q4 FY25 revenue $229M, up 11% YoY; Medical segment $152M (+5%), Industrial $77M (+25%).
- GAAP diluted EPS $0.29; Non-GAAP diluted EPS $0.37, up from $0.19 in Q4 FY24.
- FY25 revenue $845M (+4% YoY); Non-GAAP EPS $0.90 (+73%); Non-GAAP EBITDA $122M (+37%).
- Cash & securities $155M at FY25 end, down from $213M due to convertible debt paydown in June 2025.
- Q1 FY26 guidance: revenue $200-215M, Non-GAAP EPS $0.05-0.25.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681622/000168162225000106/0001681622-25-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681622/000168162225000106/vrex-20251118.htm
  HTML page:      https://secwatch.observer/filing/0001681622-25-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer